<table>
<tr>
<th>Change</th>
<th>Details of Change</th>
<th>Level of Evidence</th>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N) ☒</td>
<td>Separate N staging approaches have been described for HPV-related and HPV-unrelated cancers.</td>
<td>IT1,2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Separate N category approaches have been described for patients treated without cervical lymph node dissection (clinical N) and patients treated with cervical lymph node dissection (pathological N).</td>
<td>II1,2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Extranodal extension (ENE) is introduced as a descriptor in all HPV- unrelated cancers.</td>
<td>II2</td>
</tr>
<tr>
<td>ENE in HPV-negative cancers</td>
<td>Only clinically and radiographically overt ENE should be used for cN.</td>
<td>II2</td>
</tr>
</table>  
To access the AJCC cancer staging forms, please visit www.cancerstaging.org.  
<!-- PageFooter="American College of Surgeons 2017 M.B. Amin et al. (eds.), AJCC Cancer Staging Manual, Eighth Edition, DOI 10.1007/978-3-319-40618-3_6" -->
<!-- PageNumber="67" -->
<!-- PageBreak -->  
<!-- PageNumber="68" -->
<!-- PageHeader="American Joint Committee on Cancer . 2017" -->  
<table>
<tr>
<th>Change</th>
<th>Details of Change</th>
<th>Level of Evidence</th>
</tr>
<tr>
<td>ENE in HPV-negative cancers</td>
<td>Any pathologically detected ENE is considered ENE(+) and is used for pN.</td>
<td>II2</td>
</tr>
<tr>
<td>ENE in HPV-negative cancers</td>
<td>Presence of ENE is designated pN2a for a single ipsilateral node &lt;3 cm and pN3b for all other node(s).</td>
<td>II2</td>
</tr>
<tr>
<td>Classification of ENE</td>
<td>Clinically overt ENE is classified as ENE, and is considered ENE(+) for cN.</td>
<td>III3</td>
</tr>
<tr>
<td>Classification of ENE</td>
<td>Pathologically detected ENE is classified as either ENEmi (≤2mm) or ENEma (&gt;2 mm) for data collection purposes only but both are considered ENE(+) for definition of pN.</td>
<td>III3</td>
</tr>
<tr>
<td>Occult Primary Tumor</td>
<td>Staging of the patient who presents with EBV-unrelated and HPV- unrelated metastatic cervical lymphadenopathy is now included in this chapter.</td>
<td>IV</td>
</tr>
</table>  
#### ICD-0-3 Topography Codes  
<table>
<tr>
<th>Code</th>
<th colspan="2">Description</th>
<th>Code</th>
<th>Description</th>
</tr>
<tr>
<td>C00.0</td>
<td>External upper lip</td>
<td rowspan="32"></td>
<td>C08.1</td>
<td>Sublingual gland</td>
</tr>
<tr>
<td>C00.1</td>
<td>External lower lip</td>
<td>C08.8</td>
<td>Overlapping lesion of major salivary glands</td>
</tr>
<tr>
<td>C00.2</td>
<td>External lip, NOS</td>
<td>C08.9</td>
<td>Major salivary gland, NOS</td>
</tr>
<tr>
<td>C00.3</td>
<td>Mucosa of upper lip</td>
<td>C09.0</td>
<td>Tonsillar fossa</td>
</tr>
<tr>
<td>C00.4</td>
<td>Mucosa of lower lip</td>
<td>C09.1</td>
<td>Tonsillar pillar</td>
</tr>
<tr>
<td>C00.5</td>
<td>Mucosa of lip, NOS</td>
<td>C09.8</td>
<td>Overlapping lesion of tonsil</td>
</tr>
<tr>
<td>C00.6</td>
<td>Commissure of lip</td>
<td>C09.9</td>
<td>Tonsil, NOS</td>
</tr>
<tr>
<td>C00.8</td>
<td>Overlapping lesion of lip</td>
<td>C10.0</td>
<td>Vallecula</td>
</tr>
<tr>
<td>C00.9</td>
<td>Lip, NOS</td>
<td>C10.1</td>
<td>Anterior surface of epiglottis</td>
</tr>
<tr>
<td>C01.9</td>
<td>Base of tongue, NOS</td>
<td>C10.2</td>
<td>Lateral wall of oropharynx</td>
</tr>
<tr>
<td>C02.0</td>
<td>Dorsal surface of tongue, NOS</td>
<td>C10.3</td>
<td>Posterior wall of oropharynx</td>
</tr>
<tr>
<td>C02.1</td>
<td>Border of tongue</td>
<td>C10.4</td>
<td>Branchial cleft</td>
</tr>
<tr>
<td>C02.2</td>
<td>Ventral surface of tongue, NOS</td>
<td>C10.8</td>
<td>Overlapping lesions of oropharynx</td>
</tr>
<tr>
<td>C02.3</td>
<td>Anterior 2/3 of tongue, NOS</td>
<td>C10.9</td>
<td>Oropharynx, NOS</td>
</tr>
<tr>
<td>C02.4</td>
<td>Lingual tonsil</td>
<td>C12.9</td>
<td>Pyriform sinus</td>
</tr>
<tr>
<td>C02.8</td>
<td>Overlapping lesion of tongue</td>
<td>C13.0</td>
<td>Postcricoid region</td>
</tr>
<tr>
<td>C02.9</td>
<td>Tongue, NOS</td>
<td>C13.1</td>
<td>Hypopharyngeal aspect of aryepiglottic fold</td>
</tr>
<tr>
<td>C03.0</td>
<td>Upper gum</td>
<td>C13.2</td>
<td>Posterior wall of hypopharynx</td>
</tr>
<tr>
<td>C03.1</td>
<td>Lower gum</td>
<td>C13.8</td>
<td>Overlapping lesion of hypopharynx</td>
</tr>
<tr>
<td>C03.9</td>
<td>Gum, NOS</td>
<td>C13.9</td>
<td>Hypopharynx, NOS</td>
</tr>
<tr>
<td>C04.0</td>
<td>Anterior floor of mouth</td>
<td>C14.0</td>
<td>Pharynx, NOS</td>
</tr>
<tr>
<td>C04.1</td>
<td>Lateral floor of mouth</td>
<td>C14.2</td>
<td>Waldeyer's ring</td>
</tr>
<tr>
<td>C04.8</td>
<td>Overlapping lesion of floor of mouth</td>
<td rowspan="2">C14.8</td>
<td>Overlapping lesion of lip, oral cavity, and</td>
</tr>
<tr>
<td>C04.9</td>
<td>Floor of mouth, NOS</td>
<td>pharynx</td>
</tr>
<tr>
<td>C05.0</td>
<td>Hard palate</td>
<td>C30.0</td>
<td>Nasal cavity</td>
</tr>
<tr>
<td>C05.1</td>
<td>Soft palate, NOS</td>
<td>C30.1</td>
<td>Middle ear</td>
</tr>
<tr>
<td>C05.2</td>
<td>Uvula</td>
<td>C31.0</td>
<td>Maxillary sinus</td>
</tr>
<tr>
<td>C05.8</td>
<td>Overlapping lesion of palate</td>
<td>C31.1</td>
<td>Ethmoid sinus</td>
</tr>
<tr>
<td>C05.9</td>
<td>Palate, NOS</td>
<td>C31.2</td>
<td>Frontal sinus</td>
</tr>
<tr>
<td>C06.0</td>
<td>Cheek mucosa</td>
<td>C31.3</td>
<td>Sphenoid sinus</td>
</tr>
<tr>
<td>C06.1</td>
<td>Vestibule of mouth</td>
<td>C31.8</td>
<td>Overlapping lesion of accessory sinuses</td>
</tr>
<tr>
<td>C06.2</td>
<td>Retromolar area</td>
<td>C31.9</td>
<td>Accessory sinus, NOS</td>
</tr>
<tr>
<td>C06.8</td>
<td>Overlapping lesion of other and unspecified</td>
<td></td>
<td>C32.0</td>
<td>Glottis</td>
</tr>
<tr>
<td></td>
<td>parts of mouth</td>
<td></td>
<td>C32.1</td>
<td>Supraglottis</td>
</tr>
<tr>
<td>C06.9</td>
<td>Mouth, NOS</td>
<td></td>
<td>C32.2</td>
<td>Subglottis</td>
</tr>
<tr>
<td>C07.9</td>
<td>Parotid gland</td>
<td></td>
<td>C32.3</td>
<td>Laryngeal cartilage</td>
</tr>
<tr>
<td>C08.0</td>
<td colspan="2">Submandibular gland</td>
<td>C32.8</td>
<td>Overlapping lesion of larynx</td>
</tr>
</table>  
<!-- PageBreak -->  
<!-- PageNumber="69" -->
<!-- PageHeader="6 Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck" -->  
<table>
<tr>
<th>Code</th>
<th>Description</th>
</tr>
<tr>
<td>C32.9</td>
<td>Larynx, NOS</td>
</tr>
<tr>
<td>C44.0</td>
<td>Skin of lip, NOS</td>
</tr>
<tr>
<td>C44.2</td>
<td>External ear</td>
</tr>
<tr>
<td>C44.3</td>
<td>Skin of other and unspecified parts of face</td>
</tr>
<tr>
<td>C44.4</td>
<td>Skin of scalp and neck</td>
</tr>
<tr>
<td>C44.8</td>
<td>Overlapping lesion of skin</td>
</tr>
<tr>
<td>C76.0</td>
<td>Head, face or neck, NOS</td>
</tr>
<tr>
<td>C80.9</td>
<td>Unknown primary site</td>
</tr>
</table>